about
sameAs
Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease.Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary centerComparison of 24-h urinary aldosterone level and random urinary aldosterone-to-creatinine ratio in the diagnosis of primary aldosteronismEffect of Treatment on Body Fluid in Patients with Unilateral Aldosterone Producing Adenoma: Adrenalectomy versus Spironolactone.Prevalence of acute kidney injury and prognostic significance in patients with acute myocarditis.Quantitative breast mass classification based on the integration of B-mode features and strain features in elastography.Feasibility Testing: Three-dimensional Tumor Mapping in Different Orientations of Automated Breast Ultrasound.Whole-Breast Ultrasound for Breast Screening and Archiving.Multi-dimensional tumor detection in automated whole breast ultrasound using topographic watershed.Long-term effects of prophylactic and therapeutic lamivudine treatments in hepatitis B surface antigen-positive renal allograft recipients.MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast.Mutational analysis ofMED12exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesisColocolonic intussusception with a leading pointIntra-abdominal mass after abdominal surgeryUbiquitin carboxy-terminal hydrolase L1 may be involved in the development of mammary phyllodes tumors
P50
Q33642939-6F34F336-44A0-4497-B6A0-BE53003047E0Q33977165-3AA5EC37-0025-4862-8987-FFB0E0BC6216Q34807314-97555ECC-8441-40CD-B313-68858729F8DBQ36174691-651E0D34-396D-4106-B0BE-2879A53A06E0Q36353890-1EC5DCFB-F3F6-4D1E-88E2-90E34896BB5EQ48014129-5151C1F8-E2AA-4ED5-AB6C-4C0A21DB6FA0Q48065153-C583571A-A848-4FAC-AA03-75FA128EECA9Q48567754-BAD8ECD0-E6B4-43A1-B0B9-DC2A999814CEQ51095343-A0809188-5D32-4E2E-B460-26E9D945C8D8Q51877261-0970235F-E8DB-4F6C-8715-0F0DA655E533Q53179448-37264A59-780A-409A-AABC-D3D914C7819CQ63641914-AD2881E7-F171-4C23-86F0-780AC7DF4A8AQ82427726-95DBFC10-42A3-4448-B359-BD7E89CD1D13Q84498299-06A45CE7-3E36-4712-B120-779443A97659Q85843041-F343983C-C344-426E-ACB6-EECF7E485500
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-0412-584X
@en
name
Ya-Wen Yang
@ast
Ya-Wen Yang
@en
Ya-Wen Yang
@es
Ya-Wen Yang
@nl
type
label
Ya-Wen Yang
@ast
Ya-Wen Yang
@en
Ya-Wen Yang
@es
Ya-Wen Yang
@nl
prefLabel
Ya-Wen Yang
@ast
Ya-Wen Yang
@en
Ya-Wen Yang
@es
Ya-Wen Yang
@nl
P106
P1153
43762352200
P31
P496
0000-0003-0412-584X